D-0790-2017 Class III Terminated

Recalled by Taro Pharmaceuticals U.S.A., Inc. — Hawthorne, NY

FDA drug recall D-0790-2017 was initiated by Taro Pharmaceuticals U.S.A., Inc. on March 17, 2017 and is designated Class III. Reason for recall: Cross contamination with other products: Certain lots of Fluocinonide Cream were found to be contaminated with a small quantity of hydrocortisone-17-valerate. The recall status is terminated (terminated August 24, 2021). Affected quantity: 7,776 tubes.

Recall Details

Product Type
Drugs
Report Date
May 24, 2017
Initiation Date
March 17, 2017
Termination Date
August 24, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
7,776 tubes

Product Description

Fluocinonide Cream UPS, 0.05% (Emulsified Base), packaged in 60 g tube, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada, Dist. by Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1254-3

Reason for Recall

Cross contamination with other products: Certain lots of Fluocinonide Cream were found to be contaminated with a small quantity of hydrocortisone-17-valerate.

Distribution Pattern

U.S. Nationwide

Code Information

Lot #: D301311473, D301411473, Exp 3/2017